|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.79 / 3.85|
- Protocol Approved for Biomarker Study in up to 200 Subjects -
Biotech columnist Adam Feuerstein answers readers' questions about health care.
Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced that James A.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.